How has Intellia Therapeutics's investments and sundry assets changed year-over-year?

Intellia Therapeutics's investments and sundry assets decreased by 44.4% year-over-year, from $68.32M to $38.01M.

What is the long-term trend for Intellia Therapeutics's investments and sundry assets?

Over 5 years (2020 to 2025), Intellia Therapeutics's investments and sundry assets has grown at a 49.6% compound annual growth rate (CAGR), from $4.75M to $35.54M.

Intellia Therapeutics NTLA Investments and sundry assets

Investments and sundry assets at other companies

AmetekAME

$637.03M+25.1%

Xcel EnergyXEL

$4.34B+11.5%

Ivanhoe ElectricIE

$1.77M-4.0%

Duke EnergyDUK

$50.92B+4.1%

ABM IndustriesABM

$30.9M+12.8%

Norfolk SouthernNSC

$4.12B+2.8%

Other financials

Income statement

See full

Revenue$15.0M-9.5%

Operating income-$100.5M+16.8%

Net income-$96.2M+15.8%

EPS (diluted)-$0.81+26.4%

Balance sheet

See full

Cash & equivalents$134.7M+6.2%

Total debt$80.5M-32.5%

Total equity$620.9M-20.4%

Total assets$758.8M-23.1%

Cash flow

See full

Operating cash flow-$117.3M+21.2%

CapEx$79.0K-89.3%

Free cash flow-$117.4M+21.5%

Valuation

See full

Market cap$2.17B+106%

Profitability

See full

Operating margin-636.6%-202pp

Net margin-597%-194pp

FCF margin-550.2%-140pp

Returns & leverage

See full

Return on equity-56.3%-1.5pp

Debt / equity0.1×0.0×

Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:InvestmentsAndOtherNoncurrentAssets.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's investments and sundry assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Intellia Therapeutics's investments and sundry assets?: Intellia Therapeutics (NTLA) reported investments and sundry assets of $38.01M in Q1 2026.
How has Intellia Therapeutics's investments and sundry assets changed year-over-year?: Intellia Therapeutics's investments and sundry assets decreased by 44.4% year-over-year, from $68.32M to $38.01M.
What is the long-term trend for Intellia Therapeutics's investments and sundry assets?: Over 5 years (2020 to 2025), Intellia Therapeutics's investments and sundry assets has grown at a 49.6% compound annual growth rate (CAGR), from $4.75M to $35.54M.